Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting

Rimas V. Lukas; Steven J. Chmura; Ian F. Parney; Aaron Mammoser; Sonali M. Smith; Jing Li

doi:10.1093/nop/npac071

Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting

Rimas V. Lukas^*, Steven J. Chmura, Ian F. Parney, Aaron Mammoser, Sonali M. Smith, Jing Li

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Article › peer-review

Abstract

In the following brief report, we highlight the advances in the neuro-oncology space from the ASCO 2022 Annual Meeting. We put into context the phase 2 and 3 trials and how these may alter the standard of care going forward. In addition, we highlight some other earlier work that will lead to future and potentially practice-changing trials.

Original language	English (US)
Pages (from-to)	552-558
Number of pages	7
Journal	Neuro-Oncology Practice
Volume	9
Issue number	6
DOIs	https://doi.org/10.1093/nop/npac071
State	Published - Dec 1 2022

Funding

RVL is supported by NIH, National Cancer Institute (P50CA221747).

Keywords

brain metastases
glioblastoma
glioma
leptomeningeal metastases
meeting report
neuro-oncology

ASJC Scopus subject areas

Neurology
Oncology
Medicine (miscellaneous)

Access to Document

10.1093/nop/npac071

Cite this

@article{15be340779ec4ccab6f0678fc3a5b0b6,

title = "Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting",

abstract = "In the following brief report, we highlight the advances in the neuro-oncology space from the ASCO 2022 Annual Meeting. We put into context the phase 2 and 3 trials and how these may alter the standard of care going forward. In addition, we highlight some other earlier work that will lead to future and potentially practice-changing trials.",

keywords = "brain metastases, glioblastoma, glioma, leptomeningeal metastases, meeting report, neuro-oncology",

author = "Lukas, {Rimas V.} and Chmura, {Steven J.} and Parney, {Ian F.} and Aaron Mammoser and Smith, {Sonali M.} and Jing Li",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s).",

year = "2022",

month = dec,

day = "1",

doi = "10.1093/nop/npac071",

language = "English (US)",

volume = "9",

pages = "552--558",

journal = "Neuro-Oncology Practice",

issn = "2054-2577",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting

AU - Lukas, Rimas V.

AU - Chmura, Steven J.

AU - Parney, Ian F.

AU - Mammoser, Aaron

AU - Smith, Sonali M.

AU - Li, Jing

PY - 2022/12/1

Y1 - 2022/12/1

N2 - In the following brief report, we highlight the advances in the neuro-oncology space from the ASCO 2022 Annual Meeting. We put into context the phase 2 and 3 trials and how these may alter the standard of care going forward. In addition, we highlight some other earlier work that will lead to future and potentially practice-changing trials.

AB - In the following brief report, we highlight the advances in the neuro-oncology space from the ASCO 2022 Annual Meeting. We put into context the phase 2 and 3 trials and how these may alter the standard of care going forward. In addition, we highlight some other earlier work that will lead to future and potentially practice-changing trials.

KW - brain metastases

KW - glioblastoma

KW - glioma

KW - leptomeningeal metastases

KW - meeting report

KW - neuro-oncology

UR - http://www.scopus.com/inward/record.url?scp=85152725857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85152725857&partnerID=8YFLogxK

U2 - 10.1093/nop/npac071

DO - 10.1093/nop/npac071

M3 - Article

C2 - 36388417

AN - SCOPUS:85152725857

SN - 2054-2577

VL - 9

SP - 552

EP - 558

JO - Neuro-Oncology Practice

JF - Neuro-Oncology Practice

IS - 6

ER -

Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting

Abstract

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this